Australia investigates possible link of blood clot case to AstraZeneca vaccine

MELBOURNE - Australia is investigating whether a blood clotting disorder case recorded on Friday is related to the AstraZeneca coronavirus vaccine, Deputy Chief Medical Officer Professor Michael Kidd said.

Australian media reported that a 44-year-old man was admitted to a Melbourne hospital with possible clotting days after receiving the vaccine. "Investigators have not at this time confirmed a causal link with the COVID-19 AstraZeneca vaccine, but investigations are ongoing," Kidd told a televised briefing.